The co-formulation mention in the slide towards the end is interesting too. Perhaps existing drug companies looking to strengthen patent runway by buying OPT? We can only dream.
The co-formulation mention in the slide towards the end is...
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
48.5¢ |
Change
-0.035(6.73%) |
Mkt cap ! $324.7M | |||
| Open | High | Low | Value | Volume |
| 50.5¢ | 50.5¢ | 47.5¢ | $314.0K | 642.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3270 | 48.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 49.5¢ | 9056 | 2 |
View Market Depth
| Last trade - 16.10pm 06/06/2024 (20 minute delay) ? |
|
|||||
|
Last
48.5¢ |
Change
-0.035 ( 6.73 %) |
||||
| Open | High | Low | Volume | ||
| 49.0¢ | 50.0¢ | 47.5¢ | 78801 | ||
| Last updated 15.59pm 06/06/2024 ? | |||||
| OPT (ASX) Chart |